Akio Kuroda

This inventor holds 11 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1990-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akio Kuroda. Retrieved from https://idiyas.com/inventor/akio-kuroda-8x3c3u3u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11

% Patents Active = 90.9

Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 165(Granted Patents)

Location History:

Uji, JP (1994 - 1996)
Tsukuba, JP (1990 - 2002)
Osaka, JP (2007)

Company Filing History:

10 out of 940

Fujisawa Pharmaceutical Company, Ltd.

Years Active: 1990-2007

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7186731 - 2-cyanopyrrolidinecarboxamide compound (2007-03-06),

2. 6384080 - Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase (2002-05-07),

3. 6069156 - Indole derivatives as cGMP-PDE inhibitors (2000-05-30),

4. 5780633 - Process for the preparation of indolizine derivatives (1998-07-14),

5. 5530019 - Indole derivatives useful as testosterone 5.alpha.-reductase inhibitors (1996-06-25),

6. 5354759 - Angiotenin II antagonizing heterocyclic compounds (1994-10-11),

7. 5334716 - Heterocyclic derivatives (1994-08-02),

8. 5215994 - Angiotenin II antagonizing heterocyclic derivatives (1993-06-01),

9. 5210092 - Angiotensin II antagonizing heterocyclic derivatives (1993-05-11),

10. 4929639 - Oxygen-containing heterocyclic compound (1990-05-29),

11. 4916152 - Pyrrolidine derivatives as antiasthmatics (1990-04-10),

Title: The Innovative Journey of Akio Kuroda

Introduction

Akio Kuroda, a prominent inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Kuroda stands out as a creative force in the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest innovations are two noteworthy patents: the 2-cyanopyrrolidinecarboxamide compound, which is defined by the formula (I) or its pharmaceutically acceptable salts, and the development of anthranilic acid derivatives that act as inhibitors of the cGMP-phosphodiesterase. These contributions reflect Kuroda's commitment to advancing pharmaceutical science and improving health outcomes.

Career Highlights

Kuroda's professional journey includes key positions at renowned organizations such as Fujisawa Pharmaceutical Company, Ltd., and Astellas Pharma GmbH. His tenure at these companies has enabled him to leverage his innovative ideas into practical applications that benefit the healthcare industry.

Collaborations

Throughout his career, Kuroda has collaborated with talented coworkers, including Hirokazu Tanaka and Teruo Kyoto Oku. These partnerships have enriched his work and expanded the scope of his innovative efforts, underscoring the importance of teamwork in the advancement of scientific research.

Conclusion

In summary, Akio Kuroda's dedication to innovation in pharmaceutical compounds and his impressive patent portfolio solidify his reputation as a vital contributor to the field. His collaborative spirit and impactful career highlight the essential role of inventors in shaping the future of healthcare solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]